Further, other studies stated that neurodegeneration in patients with T2DM could be considerably lowered by targeting cytokines, cytokine receptors, and nuclear transcription factors linked to inflammation, like IL-6 and TNF- α, alone or in combination [48]. The gene discussed is IL6; the disease is type 2 diabetes mellitus.